Alliance Pharma COO stepping down, position to be disestablished
Alliance Pharma
44.60p
10:09 21/11/24
Healthcare products group Alliance Pharma announced on Tuesday that its chief operating officer Jeyan Heper would leave the company on 31 August.
FTSE AIM 100
3,514.62
10:15 21/11/24
FTSE AIM 50
3,907.13
10:15 21/11/24
FTSE AIM All-Share
724.38
10:15 21/11/24
Pharmaceuticals & Biotechnology
19,324.61
10:15 21/11/24
The AIM-traded firm said Heper joined on 1 February 2023, playing a significant role in identifying growth opportunities in international consumer healthcare markets and assisting the board and senior executive team in developing strategies for markets, especially in China and the US.
In a move to accelerate globalisation, bring consumers closer to the core of the business, and streamline the management structure, the board said it had decided to eliminate the COO position.
“I want to thank Jeyan for his contribution to Alliance, providing stability and valuable international consumer healthcare insights as we continue on our journey to transform to a high performing consumer healthcare company, built on a portfolio of leading, trusted and proven brands,” said chief executive officer Nick Sedgwick.
“We wish him well in his future endeavours.”
At 1140 BST, shares in Alliance Pharma were down 0.54% at 36.8p.
Reporting by Josh White for Sharecast.com.